Showing 2661-2670 of 7016 results for "".
Emerging Directions in Menin-Directed AML Therapy
https://reachmd.com/programs/cme/emerging-directions-in-menin-directed-aml-therapy/36184/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Real-World Ready: Practical Tips for Community Oncologists
https://reachmd.com/programs/cme/real-world-ready-practical-tips-for-community-oncologists/36572/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityClinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
https://reachmd.com/programs/cme/clinical-data-prompting-guideline-updates-for-subcutaneous-icis-in-melanoma/36329/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
https://reachmd.com/programs/cme/clinical-implications-of-neoadjuvant-therapy-guideline-updates-in-resectable-melanoma/36323/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
https://reachmd.com/programs/cme/modern-neuromodulation-vagus-nerve-stimulation-in-advancing-care-for-patients-with-drug-resistant-epilepsy-and-treatment-resistant-depression/33211/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Differential Diagnosis in ATTR-CM: 99mTc-PYP Scintigraphy and Diagnostic Workup
https://reachmd.com/programs/spotlight-attr-cm/attr-cm-differential-diagnosis-pyp-scintigraphy/57290/EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
https://reachmd.com/programs/cme/egfr-mutated-nsclc-with-brain-metastases-navigating-adc-treatment-decisions/56521/Apply clinical evidence and multidisciplinary strategies to select and sequence systemic and local therapies for brain metastases in breast and lung cancer.Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
https://reachmd.com/programs/cme/sequencing-systemic-and-local-therapy-in-her2-overexpressing-metastatic-nsclc/56520/Apply clinical evidence and multidisciplinary strategies to select and sequence systemic and local therapies for brain metastases in breast and lung cancer.Daily Contact Lenses for New and Existing Patients
https://reachmd.com/programs/empower/daily-contact-lenses-for-new-and-existing-patients/56896/A high-concept guide on getting patients into dailies, switching patients to a different daily, and ensuring that patients are equipped for success.Expanding the Role of Hormonal Therapy and Isotretinoin in Acne Care
https://reachmd.com/programs/clinicians-roundtable/hormonal-isotretinoin-acne-care/49089/Explore when and how hormonal therapy and isotretinoin can optimize acne outcomes with Dr. John Barbieri. Challenging outdated assumptions, Dr. Barbieri advocates for broader use of hormonal therapies like spironolactone, clascoterone, and oral contraceptives beyond the traditional subset of adult w